Review



pre amplified product  (Gold Standard Diagnostics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Gold Standard Diagnostics pre amplified product
    Flow diagram of participant recruitment and screening methodology. Two cohorts were included in this study: ( A ) Clinically validated samples used for optimizing <t>the</t> <t>pre-amplified</t> <t>product-to-gDNA</t> mixing ratio and comparing MLDP-AS performance against gold-standard diagnostics. ( B ) Prospective clinical screening samples tested using MLDP-AS. All detected pathogenic variants were confirmed by orthogonal methods, including Sanger sequencing, MLPA, or qPCR, to evaluate the specificity of MLDP-AS
    Pre Amplified Product, supplied by Gold Standard Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pre+amplified+product/pmc13011770-66-17-26?v=Gold+Standard+Diagnostics
    Average 86 stars, based on 1 article reviews
    pre amplified product - by Bioz Stars, 2026-07
    86/100 stars

    Images

    1) Product Images from "MLDP-AS: an optimized next-generation sequencing assay for enhanced detection of technically challenging variants in expanded carrier screening"

    Article Title: MLDP-AS: an optimized next-generation sequencing assay for enhanced detection of technically challenging variants in expanded carrier screening

    Journal: Journal of Translational Medicine

    doi: 10.1186/s12967-026-07735-9

    Flow diagram of participant recruitment and screening methodology. Two cohorts were included in this study: ( A ) Clinically validated samples used for optimizing the pre-amplified product-to-gDNA mixing ratio and comparing MLDP-AS performance against gold-standard diagnostics. ( B ) Prospective clinical screening samples tested using MLDP-AS. All detected pathogenic variants were confirmed by orthogonal methods, including Sanger sequencing, MLPA, or qPCR, to evaluate the specificity of MLDP-AS
    Figure Legend Snippet: Flow diagram of participant recruitment and screening methodology. Two cohorts were included in this study: ( A ) Clinically validated samples used for optimizing the pre-amplified product-to-gDNA mixing ratio and comparing MLDP-AS performance against gold-standard diagnostics. ( B ) Prospective clinical screening samples tested using MLDP-AS. All detected pathogenic variants were confirmed by orthogonal methods, including Sanger sequencing, MLPA, or qPCR, to evaluate the specificity of MLDP-AS

    Techniques Used: Amplification, Sequencing



    Similar Products

    pre amplified product  (Gold Standard Diagnostics)
    86
    Gold Standard Diagnostics pre amplified product
    Flow diagram of participant recruitment and screening methodology. Two cohorts were included in this study: ( A ) Clinically validated samples used for optimizing <t>the</t> <t>pre-amplified</t> <t>product-to-gDNA</t> mixing ratio and comparing MLDP-AS performance against gold-standard diagnostics. ( B ) Prospective clinical screening samples tested using MLDP-AS. All detected pathogenic variants were confirmed by orthogonal methods, including Sanger sequencing, MLPA, or qPCR, to evaluate the specificity of MLDP-AS
    Pre Amplified Product, supplied by Gold Standard Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pre+amplified+product/pmc13011770-66-17-26?v=Gold+Standard+Diagnostics
    Average 86 stars, based on 1 article reviews
    pre amplified product - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    pre amplified dna product  (Thermo Fisher)
    99
    Thermo Fisher pre amplified dna product
    Flow diagram of participant recruitment and screening methodology. Two cohorts were included in this study: ( A ) Clinically validated samples used for optimizing <t>the</t> <t>pre-amplified</t> <t>product-to-gDNA</t> mixing ratio and comparing MLDP-AS performance against gold-standard diagnostics. ( B ) Prospective clinical screening samples tested using MLDP-AS. All detected pathogenic variants were confirmed by orthogonal methods, including Sanger sequencing, MLPA, or qPCR, to evaluate the specificity of MLDP-AS
    Pre Amplified Dna Product, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pre+amplified+product/pm35698878-111-59-81?v=Thermo+Fisher
    Average 99 stars, based on 1 article reviews
    pre amplified dna product - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier
    pre-amplified products  (RainDance Technologies)
    90
    RainDance Technologies pre-amplified products
    Flow diagram of participant recruitment and screening methodology. Two cohorts were included in this study: ( A ) Clinically validated samples used for optimizing <t>the</t> <t>pre-amplified</t> <t>product-to-gDNA</t> mixing ratio and comparing MLDP-AS performance against gold-standard diagnostics. ( B ) Prospective clinical screening samples tested using MLDP-AS. All detected pathogenic variants were confirmed by orthogonal methods, including Sanger sequencing, MLPA, or qPCR, to evaluate the specificity of MLDP-AS
    Pre Amplified Products, supplied by RainDance Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pre+amplified+product/pm30861105-283-0-18?v=RainDance+Technologies
    Average 90 stars, based on 1 article reviews
    pre-amplified products - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    pre amplified pcr product  (Roche)
    86
    Roche pre amplified pcr product
    Flow diagram of participant recruitment and screening methodology. Two cohorts were included in this study: ( A ) Clinically validated samples used for optimizing <t>the</t> <t>pre-amplified</t> <t>product-to-gDNA</t> mixing ratio and comparing MLDP-AS performance against gold-standard diagnostics. ( B ) Prospective clinical screening samples tested using MLDP-AS. All detected pathogenic variants were confirmed by orthogonal methods, including Sanger sequencing, MLPA, or qPCR, to evaluate the specificity of MLDP-AS
    Pre Amplified Pcr Product, supplied by Roche, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pre+amplified+product/pm30081190-102-9-21?v=Roche
    Average 86 stars, based on 1 article reviews
    pre amplified pcr product - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    pre-amplified pcr product  (Macrogen)
    90
    Macrogen pre-amplified pcr product
    Flow diagram of participant recruitment and screening methodology. Two cohorts were included in this study: ( A ) Clinically validated samples used for optimizing <t>the</t> <t>pre-amplified</t> <t>product-to-gDNA</t> mixing ratio and comparing MLDP-AS performance against gold-standard diagnostics. ( B ) Prospective clinical screening samples tested using MLDP-AS. All detected pathogenic variants were confirmed by orthogonal methods, including Sanger sequencing, MLPA, or qPCR, to evaluate the specificity of MLDP-AS
    Pre Amplified Pcr Product, supplied by Macrogen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pre+amplified+product/pm26096543-75-1-32?v=Macrogen
    Average 90 stars, based on 1 article reviews
    pre-amplified pcr product - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    pre amplified product  (fluidigm)
    96
    fluidigm pre amplified product
    Flow diagram of participant recruitment and screening methodology. Two cohorts were included in this study: ( A ) Clinically validated samples used for optimizing <t>the</t> <t>pre-amplified</t> <t>product-to-gDNA</t> mixing ratio and comparing MLDP-AS performance against gold-standard diagnostics. ( B ) Prospective clinical screening samples tested using MLDP-AS. All detected pathogenic variants were confirmed by orthogonal methods, including Sanger sequencing, MLPA, or qPCR, to evaluate the specificity of MLDP-AS
    Pre Amplified Product, supplied by fluidigm, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pre+amplified+product/pm23935951-83-1-12?v=fluidigm
    Average 96 stars, based on 1 article reviews
    pre amplified product - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Flow diagram of participant recruitment and screening methodology. Two cohorts were included in this study: ( A ) Clinically validated samples used for optimizing the pre-amplified product-to-gDNA mixing ratio and comparing MLDP-AS performance against gold-standard diagnostics. ( B ) Prospective clinical screening samples tested using MLDP-AS. All detected pathogenic variants were confirmed by orthogonal methods, including Sanger sequencing, MLPA, or qPCR, to evaluate the specificity of MLDP-AS

    Journal: Journal of Translational Medicine

    Article Title: MLDP-AS: an optimized next-generation sequencing assay for enhanced detection of technically challenging variants in expanded carrier screening

    doi: 10.1186/s12967-026-07735-9

    Figure Lengend Snippet: Flow diagram of participant recruitment and screening methodology. Two cohorts were included in this study: ( A ) Clinically validated samples used for optimizing the pre-amplified product-to-gDNA mixing ratio and comparing MLDP-AS performance against gold-standard diagnostics. ( B ) Prospective clinical screening samples tested using MLDP-AS. All detected pathogenic variants were confirmed by orthogonal methods, including Sanger sequencing, MLPA, or qPCR, to evaluate the specificity of MLDP-AS

    Article Snippet: Two cohorts were included in this study: ( A ) Clinically validated samples used for optimizing the pre-amplified product-to-gDNA mixing ratio and comparing MLDP-AS performance against gold-standard diagnostics. ( B ) Prospective clinical screening samples tested using MLDP-AS.

    Techniques: Amplification, Sequencing